Pricing Log in Create free account

Caris Life Sciences,�Inc. (CAI) vs Bio-Techne Corp (TECH)

Caris Life Sciences,�Inc. and Bio-Techne Corp are both Biotechnology companies. Bio-Techne Corp is the larger, with a market value of $11.4B against $9.7B — 1.2× the size. Bio-Techne Corp trades at the lower P/E: 62.1× against 86.1×. Caris Life Sciences,�Inc. grew revenue faster over the last twelve months: 96.4% against −0.38%. Bio-Techne Corp has the higher net margin (15.0% vs 10.6%) and the lower return on invested capital (7.70% vs 50.0%). Across the 20 metrics below, Bio-Techne Corp leads on 11 and Caris Life Sciences,�Inc. on 9.

Valuation

Metric CAI TECH Biotechnology median
P/E 86.06 62.11 10.71
P/S 9.25 9.33 9.84
P/B 15.47 5.38 2.15
Price to free cash flow 73.83 43.06 25.78
EV/EBITDA 48.62 32.30 0.65
EV/Sales 8.84 9.29 9.47
Earnings yield 1.16% 1.61% (34.53%)
Free cash flow yield 1.35% 2.32% (24.00%)

Profitability

Metric CAI TECH Biotechnology median
Gross margin 69.66% 65.77% 69.20%
Operating margin 15.49% 20.73% 0.00%
Net margin 10.62% 14.97% 0.00%
Free cash flow margin 12.53% 21.66% 0.00%
Return on equity 20.13% 9.03% (53.10%)
Return on assets 9.62% 7.07% (46.06%)
Return on invested capital 49.95% 7.70% 0.00%

Growth

Metric CAI TECH Biotechnology median
Revenue growth (TTM) 96.36% (0.38%) 5.26%
EPS growth (last fiscal year) 69.79% 152.17% 29.88%
Revenue growth, 5-year CAGR — 5.47% 9.75%
Net income growth, 5-year CAGR — 5.31% 0.00%

Health

Metric CAI TECH Biotechnology median
Debt to equity 0.66 0.09 0.00
Current ratio 5.53 4.55 4.98
Net debt to EBITDA (5.23) (0.19) 1.01

Dividend

Metric CAI TECH Biotechnology median
Dividend yield — 0.44% 0.39%
Payout ratio — 0.28 —

Size

Metric CAI TECH Biotechnology median
Market cap 9.70b 11.41b 171.46m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack